Understanding CAR-T Therapy
Understanding how CAR-T cell therapy works, why it differs from other cancer treatments, and what to expect during treatment
CAR-T cell therapy is one of the most advanced forms of cancer treatment available today.
Unlike chemotherapy, radiotherapy or targeted therapies, CAR-T therapy uses the patient's own immune cells, which are genetically modified to recognise and attack cancer cells.
This highly personalised treatment has produced remarkable results in certain blood cancers, particularly for patients whose disease has not responded to conventional treatments.
Because CAR-T therapy works in a unique way, it is associated with specific benefits, risks and recovery challenges that differ from those of other cancer treatments.
Understanding how CAR-T therapy works helps patients and families feel more informed and prepared throughout the treatment journey.
What Is CAR-T Therapy?
CAR-T stands for Chimeric Antigen Receptor T-Cell Therapy
The treatment involves collecting a patient's own T-cells, a type of immune cell responsible for identifying and destroying abnormal cells.
These T-cells are then modified in a specialised laboratory so that they can recognise a specific marker found on cancer cells.
Once modified, the cells are multiplied and returned to the patient, where they can seek out and attack cancer cells more effectively.
CAR-T therapy is therefore a highly personalised form of immunotherapy.
How Does CAR-T Cell Therapy Work?
The process occurs in several stages.
Step 1 – Collection of T-Cells
Blood is collected through a procedure called 'leukapheresis'.
This allows T-cells to be separated from the rest of the blood.
Step 2 – Genetic Modification
In the laboratory, the T-cells are genetically modified to produce specialised receptors called 'Chimeric Antigen Receptors' (CARs).
These receptors act like highly specialised sensors that help the immune cells recognise cancer cells.
Step 3 – Expansion
The modified cells are multiplied to produce millions of CAR-T cells.
Step 4 – Preparation Treatment
Before CAR-T cells are infused, patients often receive a short course of chemotherapy.
This is known as 'lymphodepletion'.
Its purpose is to prepare the immune system to receive the CAR-T cells.
Step 5 – CAR-T Cell Infusion
The modified cells are infused back into the patient.
Once inside the body, they begin searching for cancer cells carrying the target marker.
Step 6 – Immune Attack
The CAR-T cells identify cancer cells, attach to them and destroy them.
Unlike many other treatments, CAR-T cells may continue working long after the infusion itself.
Which Cancers Can Be Treated With Antibody-based Therapies
CAR-T therapy is currently used primarily for certain blood cancers, including:
-
Diffuse Large B-Cell Lymphoma (DLBCL)
-
Acute Lymphoblastic Leukaemia (ALL)
-
Mantle Cell Lymphoma
-
Follicular Lymphoma
-
Multiple Myeloma
-
Certain other lymphomas and blood cancers
Research is ongoing to determine whether CAR-T therapies can be used effectively in solid tumours.
How Is CAR-T Therapy Different From Other Treatments?
Many patients find it helpful to compare CAR-T therapy with other common cancer treatments:
Treatment
-
Chemotherapy
-
Radiotherapy
-
Targeted Therapy
-
Antibody Therapy
-
Immunotherapy
-
CAR-T Cell Therapy
Main strategie
-
Directly damages rapidly dividing cancer cells
-
Uses radiation to destroy cancer cells in a specific area
-
Blocks specific pathways used by cancer cells
-
Uses specialised antibodies to target cancer cells
-
Helps the immune system recognise and attack cancer
-
Genetically modifies the patient's own immune cells to attack cancer
CAR-T therapy is unique because the treatment itself becomes a living population of immune cells that can continue functioning after infusion.
Why Can CAR-T Therapy Cause Side Effects?
CAR-T therapy is designed to create a powerful immune response.
While this can be highly effective against cancer, it can also lead to significant immune activation.
Unlike chemotherapy, where side effects often result from damage to rapidly dividing cells, CAR-T side effects are generally related to the intensity of the immune response.
This is why patients are monitored very closely during and after treatment.
Common Side Effects of CAR-T Cell Therapy
Not everyone experiences side effects, and many people tolerate treatment well.
However, some common challenges include:
Cytokine Release Syndrome (CRS)
CRS is one of the most common complications of CAR-T therapy.
When CAR-T cells become activated, they release large quantities of immune signalling molecules called cytokines.
This can cause symptoms such as:
-
Fever
-
Chills
-
Fatigue
-
Low blood pressure
-
Increased heart rate
-
Breathing difficulties
Most cases are manageable when recognised early.
Neurological Effects (ICANS)
Some patients develop neurological symptoms known as Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
Symptoms may include:
-
Confusion
-
Difficulty speaking
-
Memory problems
-
Reduced concentration
-
Drowsiness
-
Tremors
Most cases improve with appropriate medical management.
Fatigue
Fatigue is common both during treatment and recovery.
Some individuals experience reduced energy levels for weeks or months after treatment.
Reduced Blood Counts
Temporary reductions in:
-
White blood cells
-
Red blood cells
-
Platelets
may occur following treatment.
Cognitive Difficulties
Some patients report:
-
Reduced concentration
-
Mental fatigue
-
Memory difficulties
particularly during the recovery period.
Emotional Wellbeing
The intensity of treatment, uncertainty and recovery challenges can affect emotional wellbeing and quality of life.
Reduced Immune Function
CAR-T therapy may temporarily affect immune function.
Patients are therefore monitored carefully for signs of infection during recovery.
When Should You Contact Your Oncology Team?
Always follow the advice provided by your specialist CAR-T team.
Contact your healthcare team immediately if you experience:
-
A temperature of 38°C or above
-
New confusion
-
Difficulty speaking
-
Severe headache
-
Breathlessness
-
Dizziness
-
Chest pain
-
Rapidly worsening symptoms
-
Any symptom specifically highlighted by your treatment team
Because CAR-T therapy can produce serious immune-related complications, early reporting is essential.
Why Early Support Matters
CAR-T therapy involves a unique treatment journey that often includes:
-
Previous cancer treatments
-
Hospital admission
-
Intensive monitoring
-
A period of physical and emotional recovery
Many patients experience challenges that extend beyond the treatment itself.
These may include:
-
Fatigue
-
Reduced physical function
-
Cognitive difficulties
-
Emotional adjustment
-
Recovery of confidence and independence
Early supportive care can help patients prepare for treatment and navigate recovery more effectively.
How Rowan Health Supports Patients
At Rowan Health, support is organised around personalised treatment-pathway support protocols rather than standardised treatment packages.
CAR-T therapy presents unique recovery challenges.
Our approach aims to anticipate these challenges, identify areas of vulnerability early and provide proactive support throughout recovery and survivorship.
Step 1 – Understanding the Treatment Pathway
We begin by understanding:
The cancer diagnosis
Previous treatments received
The CAR-T protocol
Current symptoms
Recovery goals
Step 2 - Identifying Areas of Vulnerability
We assess factors most likely to affect quality of life, including:
-
Fatigue
-
Cognitive function
-
Physical recovery
-
Sleep quality
-
Emotional wellbeing
-
Confidence and independence
Step 3 – Building a Personalised Support Protocol
Depending on the individual's needs, the protocol may combine:
-
Symptom management
-
Rehabilitation
-
Recovery support
-
Education and self-management strategies
-
Selected therapeutic interventions
Step 4 - Monitoring, Adapting & Supporting Recovery
Recovery after CAR-T therapy is often dynamic and may continue for many months.
Protocols are reviewed and adapted as symptoms evolve and recovery priorities change.
Our Goal
Our objective is not simply to respond to symptoms as they arise.
It is to provide proactive, coordinated support that helps individuals:
-
Maintain function and independence
-
Strengthen resilience
-
Improve quality of life
-
Support recovery and rehabilitation
-
Reduce the burden associated with treatment
-
Navigate survivorship with confidence
By understanding the treatment pathway, anticipating likely challenges and adapting support over time, we aim to help patients navigate treatment and recovery as successfully as possible.
Areas We Commonly Support During CAR-T Therapy Recovery
Not everyone experiences the same side effects.
However, some important treatment-related effects include:
Fatigue and Reduced Energy
Many individuals experience persistent fatigue during recovery.
Energy levels may fluctuate considerably, and some patients require time to rebuild stamina and confidence in daily activities.
Cognitive Difficulties
Changes in concentration, memory and mental clarity can occur during recovery.
Some individuals describe these symptoms as "brain fog" or feeling mentally slower than usual.
Although recovery often occurs gradually, these symptoms can temporarily affect work, independence and confidence.
Physical Recovery
Following intensive treatment and hospitalisation, some patients experience:
-
Reduced strength
-
Reduced endurance
-
Deconditioning
-
Reduced confidence in physical activity
Recovery often continues for months after treatment.
Sleep Difficulties
Sleep disruption is common during and after treatment.
Changes in routine, hospitalisation, anxiety and physical symptoms may all contribute to reduced sleep quality.
Emotional Wellbeing
The CAR-T journey can be emotionally demanding.
Many patients experience:
-
Anxiety
-
Uncertainty
-
Concerns about relapse
-
Difficulties adjusting after treatment
These experiences are common and may continue during recovery.
Recovery and Survivorship
For many patients, CAR-T therapy represents a major turning point in their cancer journey.
Recovery often involves adapting to a new phase of life, rebuilding confidence and navigating the transition from active treatment to survivorship.
About this information
This article has been prepared by Julien Baron-Meyet, Consultant in Integrative & Supportive Care, with over 20 years' clinical experience supporting people living with cancer and complex health conditions.
The information on this page is intended for education and should complement—not replace—the advice of your healthcare team.
Related Resources
Help Others Understand Their Cancer Journey
Share this page